The HealthXL community brings together thought leaders and change-makers in digital health. On digital health, your opinions are the zeitgeist, we created our Polls feature to honor that. Here’s a summary of last week's vote:
Poll: In a drug + DTx combination, should both pharma and DTx change their products' claims?
We will deep dive into this in our next meeting on: `Combined Label Claims for Drug + DTx Combinations`. Join the conversation here.
We release a new poll every Monday and Wednesday. This Wednesday's poll asks: `What should DTx consider when selecting the right partner?`. You can vote here.
You can see the poll result as soon as you vote and you can track poll results over time, for this week you can vote and see the poll here.